{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9NZQ7",
      "entity_text" : "PD-L1",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "Organ" : [ "uberon:UBERON:0000479" ],
      "CellType" : [ "cl:CL:0000738" ]
    }
  },
  "verbose_text" : "Moreover, expression levels of PD-L1 on tumors that are classically associated with clinical response widely range from 14% to 100%, while there are cases of robust responses amongst patients with no expression, at least according to IHC analysis XREF_BIBR, XREF_BIBR, XREF_BIBR, XREF_BIBR.",
  "reading_complete" : "2020-08-02T09:41:06Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T09:39:06Z",
  "trigger" : "levels",
  "evidence" : [ "levels of PD-L1" ],
  "pmc_id" : "6037030",
  "score" : 0
}